Q2 2015

Source filing unavailable

Q2 2015 · —

Revenue—

Net Income

-$5.52M

N/M vs Q2 2014

EPS, diluted—

Operating Income-$4,961,000N/M

Operating Cash Flowderived-$5,705,951—

Free Cash Flowderived-$6,067,043—

Same quarter

Metric	Q2 2015	Q2 2014
Net Income	-$5.52M	-$3.01M

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR